Active Shortage Injection Endocrinology/Metabolism
Sodium Acetate Injection · 3,873 days since initial FDA posting
Brand: SODIUM ACETATE
FDA lists Sodium Acetate Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Sodium Acetate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sodium Acetate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)
- Package NDC
- 0409-3299-25
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 3, 2016
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Sodium Shortage Records
Sodium Acetate Injection
Fresenius Kabi USA, LLC
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Acetate Injection
Hospira, Inc., a Pfizer Company
Injection